GlassScriptPhysician profile
Sara Sanders
NPI 1710769260
$1,317.91
in general payments reported to CMS, 2019-2025
19 companies · $734 in 2025
The $734 reported for 2025 was more than what 92% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.19 · 2024: $551 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $369.30 | 2024-2025 | Zurzuvae |
| Organon LLC | $232.79 | 2023-2025 | Nexplanon |
| Astellas Pharma US INC | $115.04 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $97.72 | 2023-2024 | Accrufer |
| Novo Nordisk INC | $62.86 | 2024-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $61.55 | 2024-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $55.11 | 2025 | |
| Exact Sciences Corporation | $55.00 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $47.60 | 2025 | Evenity |
| Abbvie INC. | $35.64 | 2024-2025 | |
| Millicent US INC | $33.78 | 2025 | Femlyv, Intrarosa |
| Daiichi Sankyo INC. | $26.90 | 2024 | Injectafer |
| Axonics, INC. | $20.42 | 2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $20.17 | 2025 | Gardasil 9 |
| Ethicon US, LLC | $19.82 | 2025 | Vicryl |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $19.43 | 2024 | |
| Coopersurgical, INC. | $17.23 | 2024 | Paragard T 380a |
| Exeltis, USA INC. | $14.33 | 2024 | Slynd |
| Hologic Sales and Service, LLC | $13.22 | 2024 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.